Hamilton Lane Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
AA
Hamilton Lane Advisors's CDLX Position: Q1 2020 in Review
Hamilton Lane Advisors sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 2,171 shares — an estimated $1.36M sold.
Hamilton Lane Advisors first reported a position in CDLX in Q3 2018 and held it in 2 quarters. The position peaked at $1.36M in Q4 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.
- Hamilton Lane Advisors reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
- Hamilton Lane Advisors sold 2,171 Cardlytics shares in Q1 2020, an estimated $1.36M.
- Hamilton Lane Advisors first reported a position in Cardlytics in Q3 2018 and held it in 2 quarters.
- Hamilton Lane Advisors's Cardlytics position peaked at $1.36M in Q4 2019.
- 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.
Based on Hamilton Lane Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.